Infection control practices and immune modification to prevent nosocomial sepsis in hospitalized newborn infants

Research output: Contribution to journalArticle

Abstract

The incidence of nosocomial septicemia is extremely common in immature, newborn infants receiving intensive care. Developmental facets of host defense, medical interventions, and the hospital environment contribute to the septicemia rate exceeding 40% in extremely low birth weight infants. There is growing evidence that multifaceted, collaborative quality improvement measures may decrease infection rates; however, the effective implementation of these measures requires introspection and detailed analysis of hospital-specific infection control practices. Immune augmentation with human milk has been shown to effectively reduce nosocomial infections. The efficacy of pharmacologic agents such as polyclonal intravenous immune globulin and colony stimulating factors to reduce nosocomial infections has been mixed. Systemic antimicrobial prophylaxis may decrease staphylococcal and Candida spp infection rates in hospitalized infants, but this therapy carries the risks of alteration in host microbial flora as well as the development of antimicrobial resistance. Specifically targeted immunotherapy with hyperimmunoglobulin preparations, monoclonal antibodies and probiotics are currently being investigated and may become effective tools to reduce nosocomial infections in the future.

Original languageEnglish (US)
Pages (from-to)73-82
Number of pages10
JournalJournal of Pediatric Infectious Diseases
Volume1
Issue number2
StatePublished - 2006
Externally publishedYes

Fingerprint

Infection Control
Cross Infection
Sepsis
Newborn Infant
Extremely Low Birth Weight Infant
Neonatal Intensive Care
Colony-Stimulating Factors
Intravenous Immunoglobulins
Probiotics
Human Milk
Quality Improvement
Infection
Candida
Immunotherapy
Monoclonal Antibodies
Incidence
Therapeutics

Keywords

  • Neonate
  • Nosocomial sepsis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases

Cite this

@article{4746861c0d354987b5d08dde868c35bf,
title = "Infection control practices and immune modification to prevent nosocomial sepsis in hospitalized newborn infants",
abstract = "The incidence of nosocomial septicemia is extremely common in immature, newborn infants receiving intensive care. Developmental facets of host defense, medical interventions, and the hospital environment contribute to the septicemia rate exceeding 40{\%} in extremely low birth weight infants. There is growing evidence that multifaceted, collaborative quality improvement measures may decrease infection rates; however, the effective implementation of these measures requires introspection and detailed analysis of hospital-specific infection control practices. Immune augmentation with human milk has been shown to effectively reduce nosocomial infections. The efficacy of pharmacologic agents such as polyclonal intravenous immune globulin and colony stimulating factors to reduce nosocomial infections has been mixed. Systemic antimicrobial prophylaxis may decrease staphylococcal and Candida spp infection rates in hospitalized infants, but this therapy carries the risks of alteration in host microbial flora as well as the development of antimicrobial resistance. Specifically targeted immunotherapy with hyperimmunoglobulin preparations, monoclonal antibodies and probiotics are currently being investigated and may become effective tools to reduce nosocomial infections in the future.",
keywords = "Neonate, Nosocomial sepsis",
author = "Robert Schelonka",
year = "2006",
language = "English (US)",
volume = "1",
pages = "73--82",
journal = "Journal of Pediatric Infectious Diseases",
issn = "1871-0336",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Infection control practices and immune modification to prevent nosocomial sepsis in hospitalized newborn infants

AU - Schelonka, Robert

PY - 2006

Y1 - 2006

N2 - The incidence of nosocomial septicemia is extremely common in immature, newborn infants receiving intensive care. Developmental facets of host defense, medical interventions, and the hospital environment contribute to the septicemia rate exceeding 40% in extremely low birth weight infants. There is growing evidence that multifaceted, collaborative quality improvement measures may decrease infection rates; however, the effective implementation of these measures requires introspection and detailed analysis of hospital-specific infection control practices. Immune augmentation with human milk has been shown to effectively reduce nosocomial infections. The efficacy of pharmacologic agents such as polyclonal intravenous immune globulin and colony stimulating factors to reduce nosocomial infections has been mixed. Systemic antimicrobial prophylaxis may decrease staphylococcal and Candida spp infection rates in hospitalized infants, but this therapy carries the risks of alteration in host microbial flora as well as the development of antimicrobial resistance. Specifically targeted immunotherapy with hyperimmunoglobulin preparations, monoclonal antibodies and probiotics are currently being investigated and may become effective tools to reduce nosocomial infections in the future.

AB - The incidence of nosocomial septicemia is extremely common in immature, newborn infants receiving intensive care. Developmental facets of host defense, medical interventions, and the hospital environment contribute to the septicemia rate exceeding 40% in extremely low birth weight infants. There is growing evidence that multifaceted, collaborative quality improvement measures may decrease infection rates; however, the effective implementation of these measures requires introspection and detailed analysis of hospital-specific infection control practices. Immune augmentation with human milk has been shown to effectively reduce nosocomial infections. The efficacy of pharmacologic agents such as polyclonal intravenous immune globulin and colony stimulating factors to reduce nosocomial infections has been mixed. Systemic antimicrobial prophylaxis may decrease staphylococcal and Candida spp infection rates in hospitalized infants, but this therapy carries the risks of alteration in host microbial flora as well as the development of antimicrobial resistance. Specifically targeted immunotherapy with hyperimmunoglobulin preparations, monoclonal antibodies and probiotics are currently being investigated and may become effective tools to reduce nosocomial infections in the future.

KW - Neonate

KW - Nosocomial sepsis

UR - http://www.scopus.com/inward/record.url?scp=85013590855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013590855&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 73

EP - 82

JO - Journal of Pediatric Infectious Diseases

JF - Journal of Pediatric Infectious Diseases

SN - 1871-0336

IS - 2

ER -